Alpibectir
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Alpibectir, covering 2025-03-07 to 2026-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis [Phase 2]